Fact: terbinafine supply issues (I discuss ... but it's an exceptional asset. It's a topical treatment for toenail fungus that provides a mycological cure rate of 76% in phase 3 trials.

Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) did not meet the primary endpoint in the phase ...